Great Point Partners LLC Jazz Pharmaceuticals PLC Transaction History

Great Point Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $1.41 Million - $1.68 Million	-10,500 Reduced 6.56%	149,500 $21.9 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $7.13 Million - $8.79 Million	-55,000 Reduced 25.58%	160,000 $25.5 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $3.16 Million - $4.03 Million	25,000 Added 13.16%	215,000 $28.7 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $4.96 Million - $5.9 Million	35,000 Added 22.58%	190,000 $29.6 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $20.1 Million - $24.9 Million	155,000 New	155,000 $24.1 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.